Protalix BioTherapeutics, Inc.PLXEarnings & Financial Report

NYSE · Health Care · Biological Products, (No Diagnostic Substances)

Deep AnalysisCompare

Protalix BioTherapeutics is an Israeli pharmaceutical company that manufactures a plant-based enzyme, taliglucerase alfa, which has received U.S. Food and Drug Administration approval for the treatment of Gaucher disease.